Lancet Global Health

Article	Citations
Correction to Lancet Glob Health 2021; 9: e1679–87	1095
Indonesia's first nationwide health screening programme	456
The cause of nodding syndrome remains unknown	425
Correction to Lancet Glob Health 2024; published online Sept 23. https://doi.org/10.1016/S2214-109X(24)00320-6	378
Resolving the CD4-testing crisis to help end AIDS-related deaths	355
Mpox vaccination strategies in DR Congo	354
Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: a phase 3b, prospective, open-label, non-randomised, cohort study	323
C-reactive protein: another addition to our armamentarium against tuberculosis?	315
Prenatal exposure to HIV pre-exposure prophylaxis and birth, growth, and social–emotional developmental outcomes throughout early childhood in Kenya: a prospective cohort study	313
Enhancing global cancer care for sexual and gender minority populations: regional perspectives and global implications	289
Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study	285
Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income cou	266
The drug drought in maternal health: an ongoing predicament	213
Is now the time for revisiting supplements for pregnant women?	209
The road to malaria elimination: why a robust surveillance system is imperative	195
Expanding access to long-acting HIV therapy in low-income and middle-income countries	188
Automated oxygen control for preterm infants receiving continuous positive airway pressure in southwest Nigeria: an open-label, randomised, crossover trial	179
Assessing the prevalence and impact of preserved ratio impaired spirometry in low-income and middle-income countries: a post-hoc cross-sectional analysis	178
Queering global health: a feminist and lesbian, gay, and bisexual perspective – Authors' reply	175
Periconceptional diet and the risk of gestational diabetes in south Indian women: findings from the BAngalore Nutrition Gestational diabetes LiFEstyle Study (BANGLES)	173
The future of the International Health Regulations	172
Influenza vaccination in failing hearts	166
Bringing home manufacturing of medical products	163
Preventing pellagra during isoniazid preventive treatment	161
Racism and health: the need for urgent action	160

Global health research funding applications: brain drain under another name?	155
Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical m	153
Challenges in operationalising clinical trials in India during the COVID-19 pandemic	151
Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial	150
Mortality in patients admitted to hospital with heart failure in China: a nationwide Cardiovascular Association Database-Heart Failure Centre Registry cohort study	142
Outcomes of rheumatic fever in Uganda: a prospective cohort study	138
The health status of Indonesia's provinces: the double burden of diseases and inequality gap	136
Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled tr	135
Global and regional sepsis and infectious syndrome mortality in 2019: a systematic analysis	130
Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study	117
Global patterns and trends in Kaposi sarcoma incidence: a population-based study	116
Patient-level and system-level determinants of stroke fatality across 16 large hospitals in Ghana and Nigeria: a prospective cohort study	115
Implementation of the 7-1-7 target for detection, notification, and response to public health threats in five countries: a retrospective, observational study	112
Comparison of maternal and neonatal outcomes of COVID-19 before and after SARS-CoV-2 omicron emergence in maternity facilities in Malawi (MATSurvey): data from a national maternal surveillance platfor	111
The pneumonia challenge: time to end the global neglect	111
The cost of inaction on physical inactivity to public health-care systems: a population-attributable fraction analysis	108
Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys	108
The state of health in Pakistan and its provinces and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019	100
Payment in arrears: a global health inequity that must be corrected	99
Improving access to liposomal amphotericin B worldwide	98
Mathematical modelling to accurately quantify the benefits of pneumococcal conjugate vaccine	98
Lessons for future implementation of the E-MOTIVE bundle	97
Experiences of an Israeli hospital in the management of repatriated civilian hostages	97
Correction to Lancet Glob Health 2023; 11: e1978–85	95
The social determinants of tuberculosis in the Philippines	94
Bridging the gap between science and policy in global health governance	94
Pregnancy, pregnancy outcomes, and infant growth and development after recovery from Ebola virus disease in Liberia: an observational cohort study	94
Introduction and rollout of malaria vaccines in Cameroon and Burkina Faso: early lessons learned	91
Complementary medicine as a risk factor for catastrophic expenditures in people with cancer	90
Using verbal autopsy to enhance mortality surveillance	90
Using theory to understand how interventions work and inform future implementation	88
Correction to Lancet Glob Health 2015; 3: e196	88
COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns	87
Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study	87
Changes in incidence of HPV-related cancers in South Africa (2011–21): a cross-sectional analysis of the South African National Cancer Registry	85
Routine immunisation coverage in the context of seasonal influenza vaccine introduction for children in Nakuru and Mombasa counties in Kenya, 2019–21: an observational study	85
WHO model list of essential in vitro diagnostics: strengthening diagnostics capacity to transform health care for all	84
Switching antibiotic therapy from injectable to oral to optimise the duration of inpatient care for young infants presenting with moderate-mortality-risk signs of possible serious bacterial infection:	83
Pregnancy in people who have survived Ebola virus disease	83
Mpox: evidence for strengthening and sustaining global surveillance	82
How to DREAMM and end HIV-related deaths	82
Addressing the complex needs of people with severe mental health disorders in low-resource settings	80
Commitment and innovation on the road to people-centred PHC financing	80
Addressing the social inequities of vaccination: an imperative to close the gap	78
Cervical cancer elimination: actions needed in the COVID-19 era	75
Highlighting the need for investment and innovation in ART retention interventions	75
Correction to Lancet Glob Health 2022; 10: e1443–52	74
Staying focused on protecting young people from the harms of tobacco smoke	74
Locally validated biomarker cutoffs should inform micronutrient deficiency burdens – Authors' reply	73
Cholera rapid diagnostic tests recycled for PCR confirmation	72

Next generation economics of universal HIV treatment	72
From child institutions to family reunification: challenges and opportunities in building family-centred care	71
Uncertainty in key population size estimates in sub-Saharan Africa	68
Beyond malaria: can intermittent preventive treatment with sulphadoxine-pyrimethamine reduce the number of small vulnerable newborns globally?	67
Catastrophic health expenditure during the COVID-19 pandemic in five countries: a time-series analysis	67
Aedes albopictus invasion across Africa: the time is now for cross-country collaboration and control	67
Infertility—why the silence?	66
Understanding deaths from diarrhoea in children younger than 5 years	65
Quality of inpatient paediatric and newborn care in district hospitals: WHO indicators, measurement, and improvement	65
Child, maternal, and adult mortality in Sierra Leone: nationally representative mortality survey 2018–20	64
Climate change and health: the next challenge of ethical AI	62
Reducing global inequities in medical oxygen access: the Lancet Global Health Commission on medical oxygen security	61
Advancing maternal and perinatal health through clinical trials: key insights from a WHO global consultation	59
TAK-003 dengue vaccine as a new tool to mitigate dengue in countries with a high disease burden	59
Innovative blood transfusion strategies to address global blood deserts: a consensus statement from the Blood Delivery via Emerging Strategies for Emergency Remote Transfusion (Blood DESERT) Coalition	59
A call for an Africa-centric health research ethics framework: a way forward for shaping global health research	59
The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review	58
Global, regional, and national health-care inefficiency and associated factors in 201 countries, 1995–2022: a stochastic frontier meta-analysis for the Global Burden of Disease Study 2023	57
Correction to Lancet Glob Health 2025; 13: e2013–26	56
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026	54
Sustainability of a 12-month lifestyle intervention delivered by community health workers in reducing blood pressure in Nepal: 5-year follow-up of the COBIN open-label, cluster randomised trial	54
Characterisation of febrile non-traumatic coma in sub-Saharan Africa	54
Potassium-enriched salt substitutes: supporting global cardiovascular and kidney health	53
Every baby counts: eliminating all preventable child deaths	53
Precision in prescription: multiple micronutrient supplements in pregnancy	53
Implementation strategies to build mental health-care capacity in Malawi: a health-economic evaluation	53
Low risk, high impact: the hidden burden of cardiovascular disease	53
Addressing global micronutrient inadequacies: enhancing global data representation	52
Reducing antibiotic use with diarrhoeal vaccines	52
AI for health or AI for war? Challenging the military partnerships behind climate harm	51
Migrants and displaced people: intentionally endangered and inconsistently visible	50
People who inject drugs in the Eastern Mediterranean region	50
Lots of considerations when evaluating the FujiLAM assay – Author's reply	49
Maternal intimate partner violence and child health outcomes	47
Pulse oximetry to detect paediatric hypoxaemia—the fifth vital sign	47
Withholding liberty, not the right to health	47
Hepatitis E vaccination: continued benefit for pregnant women in vulnerable settings	47
Correction to Lancet Glob Health 2022; 10: e1115–27	47
Reciprocal innovation: a new approach to equitable and mutually beneficial global health research and partnerships	46
COVID-19 in pregnancy: evidence from LMICs	46
The impact of ivermectin, diethylcarbamazine citrate, and albendazole mass drug administration on the prevalence of scabies and soil-transmitted helminths in school-aged children in three municipaliti	46
Unveiling the crisis of the double burden of malnutrition	45
Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study	44
Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis	44
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Le	44
Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b–2a, double-blind, dose-escalation, randomised controlled t	44
Respiratory syncytial virus infection among children younger than 2 years admitted to a paediatric intensive care unit with extended severe acute respiratory infection in ten Gavi-eligible countries:	44
Equity challenges in Indonesian health care	44
Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data	43
Ranking the most efficient human papillomavirus vaccination strategies in low-income and lower-middle income countries: a mathematical modelling analysis	43
Identifying gaps in the HIV treatment cascade in Africa: a model comparison study	43
Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: an analysis from the Global Congestive Heart Failure (G-CHF) regi	43
Can resistance testing improve outcomes for children and adolescents with HIV?	42
The landscape for rare diseases in 2024	42
Correction to Lancet Glob Health 2024; 12: e1389–90	42
Estimating the cost of achieving basic water, sanitation, hygiene, and waste management services in public health-care facilities in the 46 UN designated least-developed countries: a modelling study	41
The challenge of promoting physical activity in low-income and middle-income countries	41
How the EAT–Lancet Commission on food in the Anthropocene influenced discourse and research on food systems: a systematic review covering the first 2 years post-publication	40
Geospatial disparities in survival of patients with breast cancer in sub-Saharan Africa from the African Breast Cancer-Disparities in Outcomes cohort (ABC-DO): a prospective cohort study	40
Nutritional support for adult patients with microbiologically confirmed pulmonary tuberculosis: outcomes in a programmatic cohort nested within the RATIONS trial in Jharkhand, India	39
Quartile-based risk exposure in global IHD and ischaemic stroke	39
Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries	39
Cost-effectiveness of the expansion of PrEP for HIV infection in the Asia Pacific region	39
Wastewater monitoring can anchor global disease surveillance systems	39
Policy and service delivery proposals to improve primary care services in low-income and middle-income country cities	38
Climate change and the right to health of people with disabilities	38
Predicting mortality within 1 year of ART initiation in children and adolescents living with HIV in sub-Saharan Africa: a retrospective observational cohort study	38
Social and health factors associated with adverse treatment outcomes among people with multidrug-resistant tuberculosis in Sierra Leone: a national, retrospective cohort study	38
More treatment options for rifampicin-resistant tuberculosis: the role of economic evaluation in informing uptake	37
Donor aid and research funding for newborn babies and preventing stillbirths	37
Can the ShangRing bring us closer to endorsing early infant male circumcision in sub-Saharan Africa?	37
Universal health coverage is fundamental to preparing for a healthier and better tomorrow	37
Tuberculosis and undernutrition in India – Authors’ reply	37
Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines	37
Homing in on haemoglobinopathies	36
Insights from Zimbabwe's SARS-CoV-2 genomic surveillance	36
Maximising human health and development through synergistic partnerships: the African Biobank and Longitudinal Epidemiological Ecosystem	36
Clinical characteristics and outcomes of patients with cirrhosis and hepatocellular carcinoma in The Gambia, west Africa: a prospective cohort study	35
Avoiding another lost decade in reducing malaria burden in African infants and young children	35
Incidence of and risk factors for small vulnerable newborns in north India: a secondary analysis of a prospective pregnancy cohort	35

Innovative methods of determining health expenditure efficiency are urgently needed	35
Infant-level and child-level predictors of mortality in low-resource settings: the WHO Child Mortality Risk Stratification Multi-Country Pooled Cohort	35
Aminoglycosides, deafness, and non-tuberculous mycobacteria	34
Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories	34
Navigating AMR with innovative diagnostics	34
The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries	34
Nodding syndrome and doxycycline: promising findings with open questions	34
Prices, availability, and affordability of adult medicines in 54 low-income and middle-income countries: evidence based on a secondary analysis	34
National diabetes prevention programmes in LMICs are now a necessity	33
Questions about the HELIX trial	33
Postnatal morbidity: prevalent, enduring, and neglected	33
Colorectal cancer screening in sub-Saharan Africa	33
Relapse after recovery from acute malnutrition	33
Targeting malaria control to schoolchildren	33
Global variations in barriers to exercise for individuals with intellectual and developmental disability	33
Trans Reform: an initiative for the recognition of transgender rights in a university in Lima, Peru	32
Enhancing cervical and breast cancer training in Africa with e-learning	32
Colorectal cancer screening with fecal immunochemical testing in Nigeria – Authors' reply	32
Ethical considerations for introducing RTS,S/AS01 in countries with moderate to high Plasmodium falciparum malaria transmission	32
The SARS-CoV2 pandemic and routine immunisation	32
Pragmatic global health	32
Prevention of pneumococcal diseases: the challenge remains	32
Scarcity of research on breastfeeding and Ebola diseases is placing the lives of women and infants at risk: a call to specific action	31
Correction to Lancet Glob Health 2025; 13: e528–84	31
Finding balance in Nigeria's mandatory health insurance	31
Balancing global access to opioids	31
Catastrophic health expenditure and chronic respiratory disease: evidence from Kenya	31
The effect of a social network-based intervention to promote HIV testing and linkage to HIV services among fishermen in Kenya: a cluster-randomised trial	31
Correction to Lancet Glob Health 2025; 13: e309–18	31
Mpox vaccination strategies in DR Congo	31
Urgent call for the prioritisation of palliative care in Syria	31
The continuum of menstrual health through the life course	30
Individual-level and community-level factors for 10-year cardiovascular disease risk in Ethiopia: a retrospective, population-based, cross-sectional, observational study	30
The potential impact of reductions in international donor funding on tuberculosis in low-income and middle-income countries: a modelling study	30
The challenging road to universal health coverage	30
The need for epidemiological data on HIV-related CNS infections in low-income and middle-income settings	30
Correction to Lancet Glob Health 2022; 10: 1715–43	30
Defining the usefulness of oral swabs in tuberculosis diagnosis	30
Implementation science in Africa—whose epistemology counts?	30
Neonatal mortality during the war in Tigray: a cross-sectional community-based study	30
Distinguishing between mortality rates for heart failure with preserved versus reduced ejection fraction – Authors' reply	30
Enabling access to quality abortion care: WHO's Abortion Care guideline	30
The need for a One Health approach for influenza surveillance	30
Global retinoblastoma survival and globe preservation: a systematic review and meta-analysis of associations with socioeconomic and health-care factors	29
Diagnostic yield as an important metric for the evaluation of novel tuberculosis tests: rationale and guidance for future research	29
Primary care institutional characteristics associated with hypertension awareness, treatment, and control in the China PEACE-Million Persons Project and primary health-care survey: a cross-sectional s	29
Integrating mental health care to reduce intimate partner violence in complex humanitarian emergencies	29
The health toll of economic sanctions	29
Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 2 × 2 factorial randomised controlled trial	29
Combating antimicrobial resistance in neonatal infections: a South African perspective	28
Global radiotherapy demands and corresponding radiotherapy-professional workforce requirements in 2022 and predicted to 2050: a population-based study	28
Global, regional, and national causes of death in children and adolescents younger than 20 years: an open data portal with estimates for 2000–21	28
Variability and social patterning of cancer mortality in 343 Latin American cities: an ecological study	28
The effect on HIV transmission and cost-effectiveness of programmes for female sex workers in East, Central, and Southern Africa: a modelling study	28
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial	28
Short-term aid or long-term gains? Harnessing Sudan's humanitarian response for the resilience of its health system	27
Research ethics systems in Latin America and the Caribbean: a systemic assessment using indicators	27
Correction to Lancet Glob Health 2024; 12: e1209–13	27
Clinical impact and cost-effectiveness of the WHO-recommended advanced HIV disease package of care	27
Estimating dementia prevalence using remote diagnoses and algorithmic modelling: a population-based study of a rural region in South Africa	27
Monitoring the benefits of human papillomavirus vaccination in low-income and middle-income countries	27
Strengthening health-care systems to reduce child mortality	27
Prediabetes: the best opportunity to reach remission	27
Malaria guidelines fall short in diagnosing acute kidney injury	27
Antimicrobial resistance and the great divide: inequity in priorities and agendas between the Global North and the Global South threatens global mitigation of antimicrobial resistance	27
Clearing our heads over alcohol	27
Evolving crises and unprecedented need: research on health in humanitarian settings must not be overlooked	27
Redefining implementation science for global health decolonisation	26
What can we learn from developments in primary health care in south Asia?	26
Postpartum maternal and infant haematological effects of second-trimester ferric carboxymaltose versus standard-of-care oral iron in Malawi: longitudinal follow-up of a randomised controlled trial	26
Socioeconomic inequalities in palliative care access: insights from SHARE	26
Mpox outbreaks in Africa constitute a public health emergency of continental security	26
(Re-) considering success in implementation science: experiences amid a co-designed mHealth intervention in rural Uganda	26
Exposure to household air pollution from cooking fuel in Ugandan households and associated household factors: a retrospective analysis of demographic and health survey data	25
Mind the gap: rethinking global alcohol metrics in high-abstention low-income and middle-income countries	25
Maximising the value of nudge units for global health	25
Obstetric fistula in Bangladesh: estimates from a national survey with clinical validation correction	25
Effectiveness of the RTS,S/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Mal	25
Correction to Lancet Glob Health 2021; 9: e1610–17	25
Effectiveness of a new vaccine for outbreak response and the increasingly complicated polio endgame	25
Correction to Lancet Glob Health 2024; 12: e25–27	25
Prevalence, awareness, treatment, and control of diabetes in India: a nationally representative survey of adults aged 45 years and older	25
Current testing systems are a barrier to achieving the 7-1-7 target for detection, notification, and response to public health threats	25
Peripheral artery disease: a global need for detection, prevention, and treatment	25
Indigenous and minority groups in diabetes trials	25
Prevalence of all epilepsies in urban informal settlements in Nairobi, Kenya: a two-stage population-based study	25
Bridging the divide between religion and health care	25
Nigeria's mandatory health insurance and the march towards universal health coverage	24
The aetiology and prevalence of preoperative anaemia in patients undergoing major surgery (ALICE): an international, prospective, observational cohort study	24
The use of imagery in global health: an analysis of infectious disease documents and a framework to guide practice	24
COVID-19 vaccine hesitancy in Africa: a call to action	24
Countries cannot cover the shortfall from US funding cuts	24
Democratising clinical trials research to strengthen primary health care	24
Are current systems of global health academia fit for purpose?	24
Prevalence of diabetic retinopathy in India stratified by known and undiagnosed diabetes, urban–rural locations, and socioeconomic indices: results from the SMART India population-based cross-sectiona	24